Invesco’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $870K | Buy |
62,217
+14,446
| +30% | +$202K | ﹤0.01% | 2906 |
|
|
2025
Q1 | $644K | Buy |
47,771
+14,672
| +44% | +$198K | ﹤0.01% | 3040 |
|
|
2024
Q4 | $635K | Buy |
33,099
+12,350
| +60% | +$237K | ﹤0.01% | 3119 |
|
|
2024
Q3 | $472K | Buy |
20,749
+178
| +0.9% | +$4.05K | ﹤0.01% | 3244 |
|
|
2024
Q2 | $268K | Buy |
20,571
+1,841
| +10% | +$24K | ﹤0.01% | 3524 |
|
|
2024
Q1 | $328K | Sell |
18,730
-126,035
| -87% | -$2.21M | ﹤0.01% | 3485 |
|
|
2023
Q4 | $3.15M | Buy |
144,765
+116,932
| +420% | +$2.55M | ﹤0.01% | 2453 |
|
|
2023
Q3 | $427K | Buy |
27,833
+8,394
| +43% | +$129K | ﹤0.01% | 3263 |
|
|
2023
Q2 | $462K | Buy |
19,439
+789
| +4% | +$18.8K | ﹤0.01% | 3271 |
|
|
2023
Q1 | $474K | Sell |
18,650
-175,887
| -90% | -$4.47M | ﹤0.01% | 3267 |
|
|
2022
Q4 | $5.68M | Sell |
194,537
-29,779
| -13% | -$870K | ﹤0.01% | 2175 |
|
|
2022
Q3 | $4.6M | Buy |
224,316
+213,278
| +1,932% | +$4.37M | ﹤0.01% | 2264 |
|
|
2022
Q2 | $128K | Buy |
+11,038
| New | +$128K | ﹤0.01% | 3815 |
|
|
2019
Q4 | – | Sell |
-1,448
| Closed | -$16K | – | 3648 |
|
|
2019
Q3 | $16K | Sell |
1,448
-860
| -37% | -$9.5K | ﹤0.01% | 3613 |
|
|
2019
Q2 | $71K | Buy |
+2,308
| New | +$71K | ﹤0.01% | 3649 |
|